GlassScriptPhysician profile
Scott W Spann
NPI 1861487001
$24,302.28
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $460 · 2021: $253 · 2022: $67.65.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinesmith Holdings, LLC | $21,484.00 | 2019 | |
| Merck Sharp & Dohme LLC | $964.58 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $349.00 | 2020 | |
| Seaspine Orthopedics Corporation | $335.64 | 2019-2021 | |
| Alphatec Spine, INC | $202.80 | 2019 | |
| Providence Medical Technology, INC. | $174.42 | 2019 | |
| Smith+Nephew, INC. | $163.05 | 2019-2020 | |
| Abbott Laboratories | $150.22 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $148.48 | 2019 | |
| Radius Health, INC. | $98.79 | 2019 | |
| Nevro Corp. | $67.65 | 2022 | |
| Ferring Pharmaceuticals INC. | $29.49 | 2019 | |
| Medtronic USA, INC. | $25.87 | 2019 | |
| Orthogenrx INC. | $24.78 | 2019 | |
| Si-Bone, INC. | $21.00 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $19.43 | 2019 | |
| Vertiflex, INC. | $16.77 | 2019 | |
| Djo, LLC | $15.77 | 2019 | |
| Captiva Spine INC | $10.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Spann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.